Lanreotide is used in adults to treat: acromegaly that cannot be treated with surgery or radiation carcinoid syndrome. It is marketed under the trade name Somatuline.Reference standards of Lanreotide API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Lanreotide-d8
Catalogue No.:PA STI 056001
CAS :
Molecular Formula : C54H61D8N11O10S2
Molecular Weight : 1104.37
Lanreotide
Catalogue No.:PA 12 1690000
Molecular Formula : C54H69N11O10S2
Molecular Weight : 1096.33
((4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-threonine
Catalogue No.:PA 12 1691000
Molecular Formula : C54H68N10O11S2
Molecular Weight : 1097.32
N-Ac-Lanreotide
Catalogue No.:PA 12 1691001
Molecular Formula : C56H71N11O11S2
Molecular Weight : 1138.37
(4R,7S,10S,13R,16S,19R)-19-((R)-2-Amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-13-((1-nitroso-1H-indol-3-yl)methyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
Catalogue No.:PA PEP 001122
Molecular Formula : C54H68N12O11S2
Molecular Weight : 1125.33
(S)-6-Amino-2-((S)-2-((S)-2-((R)-2-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-3-mercaptopropanamido)-3-(4-hydroxyphenyl)propanamido)-3-(1H-indol-3-yl)propanamido)-N-((S)-1-((3-(((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)amino)-3-oxoprop-1-en-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide
Catalogue No.:PA PEP 001129
Molecular Formula : C54H69N11O10S
Molecular Weight : 1064.27
(3R,6S,9S,12S,15S,18R)-12-((1H-Indol-3-yl)methyl)-18-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-9-(4-aminobutyl)-15-(4-hydroxybenzyl)-6-isopropyl-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacyclononadecane-3-carboxamide
Catalogue No.:PA PEP 001130
(4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide 1-oxide
Catalogue No.:PA PEP 001131
Molecular Formula : C54H69N11O11S2
Molecular Weight : 1112.33
(4R,7S,10S,13R,16S,19R)-19-((R)-2-Amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-13-((2-oxoindolin-3-yl)methyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
Catalogue No.:PA PEP 001132
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....